Contribution of MEK Inhibition to BRAF/MEK Inhibitor Combination Treatment of BRAF-Mutant Melanoma: Part 2 of the Randomized, Open-Label, Phase III COLUMBUS Trial

Ascierto, Paolo A.; Dummer, Reinhard; Gogas, Helen J.; Arance, Ana; Mandala, Mario; Liszkay, Gabriella; Garbe, Claus; Schadendorf, Dirk; Krajsova, Ivana; Gutzmer, Ralf; Chiarion-Sileni, Vanna; Dutriaux, Caroline; de Groot, Jan Willem B.; Yamazaki, Naoya; Loquai, Carmen; Robert, Caroline; Flaherty, Keith T.

dc.contributor.author	Garbe, Claus
dc.date.accessioned	2024-06-18T08:15:01Z
dc.date.available	2024-06-18T08:15:01Z
dc.date.issued	2023
dc.identifier.issn	0732-183X
dc.identifier.uri	http://hdl.handle.net/10900/154300
dc.language.iso	en	de_DE
dc.publisher	Philadelphia : Lippincott Williams & Wilkins	de_DE
dc.relation.uri	http://dx.doi.org/10.1200/JCO.22.02322	de_DE
dc.subject.ddc	610	de_DE
dc.title	Contribution of MEK Inhibition to BRAF/MEK Inhibitor Combination Treatment of BRAF-Mutant Melanoma: Part 2 of the Randomized, Open-Label, Phase III COLUMBUS Trial	de_DE
dc.type	Article	de_DE
utue.quellen.id	20240124000000_00801
utue.publikation.seiten	4621-4631	de_DE
utue.personen.roh	Ascierto, Paolo A.
utue.personen.roh	Dummer, Reinhard
utue.personen.roh	Gogas, Helen J.
utue.personen.roh	Arance, Ana
utue.personen.roh	Mandala, Mario
utue.personen.roh	Liszkay, Gabriella
utue.personen.roh	Garbe, Claus
utue.personen.roh	Schadendorf, Dirk
utue.personen.roh	Krajsova, Ivana
utue.personen.roh	Gutzmer, Ralf
utue.personen.roh	Chiarion-Sileni, Vanna
utue.personen.roh	Dutriaux, Caroline
utue.personen.roh	de Groot, Jan Willem B.
utue.personen.roh	Yamazaki, Naoya
utue.personen.roh	Loquai, Carmen
utue.personen.roh	Robert, Caroline
utue.personen.roh	Flaherty, Keith T.
dcterms.isPartOf.ZSTitelID	Journal of Clinical Oncology	de_DE
dcterms.isPartOf.ZS-Issue	29	de_DE
dcterms.isPartOf.ZS-Volume	41	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE